Paul E. De Jong

Paul E. De Jong's AcademicInfluence.com Rankings

Paul E. De Jong

Medical

#2299

World Rank

#2714

Historical Rank

Epidemiology

#401

World Rank

#420

Historical Rank

medical Degrees

Paul E. De Jong

Philosophy

#6697

World Rank

#9781

Historical Rank

Logic

#3825

World Rank

#5038

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Paul E. De Jong's Degrees

PhD Epidemiology University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Paul E. De Jong Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul E. De Jong's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis (2010) (3137)
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (2011) (1911)
Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population (2002) (1585)
Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis (2003) (1137)
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. (2004) (967)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) (841)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) (841)
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. (2014) (745)
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. (2011) (690)
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity (2001) (681)
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease (2001) (679)
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. (2011) (645)
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria (2004) (564)
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. (2001) (529)
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. (1989) (402)
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. (2001) (389)
Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. (2000) (374)
A central body fat distribution is related to renal function impairment, even in lean subjects. (2003) (342)
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? (1994) (317)
Smoking Is Related to Albuminuria and Abnormal Renal Function in Nondiabetic Persons (2000) (301)
Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. (1995) (277)
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. (1996) (275)
Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. (2008) (248)
An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. (2004) (244)
Screening, monitoring, and treatment of albuminuria: Public health perspectives. (2006) (237)
C-reactive protein is associated with renal function abnormalities in a non-diabetic population. (2003) (225)
First morning voids are more reliable than spot urine samples to assess microalbuminuria. (2009) (223)
Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. (2000) (222)
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. (1998) (212)
Metabolic Syndrome Is Associated with Impaired Long‐term Renal Allograft Function; Not All Component criteria Contribute Equally (2004) (211)
Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes (2011) (208)
Reduction of proteinuria by angiotensin converting enzyme inhibition. (1987) (207)
A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. (1997) (207)
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. (2006) (205)
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury. (2015) (184)
Dual renin-angiotensin system blockade at optimal doses for proteinuria. (2002) (182)
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. (2008) (179)
Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. (2009) (178)
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. (2005) (174)
Hypertension and Road Traffic Noise Exposure (2007) (171)
Excessive Urinary Albumin Levels Are Associated With Future Cardiovascular Mortality in Postmenopausal Women (2001) (167)
Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. (1994) (161)
Haemodialysis is associated with a pronounced fall in myocardial perfusion. (2008) (155)
Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. (1995) (146)
The kidney, a cardiovascular risk marker, and a new target for therapy. (2005) (145)
Screening for albuminuria identifies individuals at increased renal risk. (2009) (145)
Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. (2005) (143)
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. (2003) (140)
Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. (2004) (140)
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. (2000) (138)
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. (2006) (136)
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. (2007) (135)
Pharmacy data in epidemiological studies: an easy to obtain and reliable tool (2002) (135)
Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. (2003) (129)
Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. (2003) (128)
Gender differences in predictors of the decline of renal function in the general population. (2008) (127)
Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. (1996) (126)
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. (2010) (122)
Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? (2003) (119)
Screening for chronic kidney disease: where does Europe go? (2008) (119)
Urinary albumin excretion as a predictor of the development of hypertension in the general population. (2006) (119)
Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. (2010) (116)
Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease. (1994) (114)
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention tr (2006) (112)
Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. (2013) (109)
C-Reactive Protein Modifies the Relationship Between Blood Pressure and Microalbuminuria (2004) (109)
Measurement of relative blood volume changes during haemodialysis: merits and limitations. (2005) (107)
Atrial natriuretic factor: its (patho)physiological significance in humans. (1992) (104)
The association between atherosclerotic risk factors and renal function in the general population. (2005) (104)
Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. (2001) (101)
Alcohol consumption and the risk of renal dysfunction in apparently healthy men. (2005) (99)
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. (2006) (98)
Urinary Creatinine Excretion Reflecting Muscle Mass is a Predictor of Mortality and Graft Loss in Renal Transplant Recipients (2008) (97)
Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance. (2012) (97)
From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. (2004) (96)
The case for using albuminuria in staging chronic kidney disease. (2009) (96)
Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease. (1993) (96)
Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. (1998) (96)
Association Between Sodium Intake and Change in Uric Acid, Urine Albumin Excretion, and the Risk of Developing Hypertension (2012) (94)
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. (2012) (93)
Body Mass Index and Glomerular Hyperfiltration in Renal Transplant Recipients: Cross‐Sectional Analysis and Long‐Term Impact (2007) (93)
Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. (2010) (90)
Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. (2004) (88)
Eight blood pressure loci identified by genome-wide association study of 34,433 people of European ancestry (2009) (88)
Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study. (2012) (86)
Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. (1993) (85)
Impact of weight change on albuminuria in the general population. (2007) (85)
High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. (2012) (84)
Short-term change in kidney function and risk of end-stage renal disease. (2012) (84)
Extended prognostic value of urinary albumin excretion for cardiovascular events. (2008) (84)
Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. (2011) (83)
Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake. (2002) (83)
Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. (2011) (83)
Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during followup. (1994) (81)
Effects of nonsteroidal anti-inflammatory drugs on proteinuria. (1986) (81)
Antihypertensive Effect of a 5‐Day Infusion of Atrial Natriuretic Factor in Humans (1989) (80)
Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition. (1987) (80)
Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. (2004) (80)
Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. (1996) (80)
High protein intake associates with cardiovascular events but not with loss of renal function. (2009) (79)
Development and validation of a general population renal risk score. (2011) (79)
Copeptin, a Surrogate Marker of Vasopressin, Is Associated With Accelerated Renal Function Decline in Renal Transplant Recipients (2009) (79)
Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient. (1999) (79)
Obesity and renal hemodynamics. (2006) (77)
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. (2013) (77)
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides. (2007) (76)
Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. (2011) (76)
Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples. (2005) (75)
The importance of microalbuminuria as a cardiovascular risk indicator: A review. (2002) (74)
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides. (2005) (74)
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension? (1996) (73)
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND I (2000) (73)
Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. (1993) (72)
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function. (2015) (71)
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. (2012) (70)
Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal disease. (2009) (70)
N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Renal Transplant Recipients Versus the General Population (2009) (70)
Relative blood volume changes underestimate total blood volume changes during hemodialysis. (2007) (69)
Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status. (1997) (68)
Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. (2006) (66)
C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. (2004) (65)
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. (2010) (64)
Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria. (1994) (64)
Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes. (2002) (64)
Low Levels of Urinary Albumin Excretion Are Associated with Cardiovascular Risk Factors in the General Population (2000) (63)
The reliability of different formulae to predict creatinine clearance (2003) (63)
Early renal abnormalities in autosomal dominant polycystic kidney disease. (2010) (63)
Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease. (1991) (62)
Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. (2005) (61)
Fact or fiction of the epidemic of chronic kidney disease--let us not squabble about estimated GFR only, but also focus on albuminuria. (2007) (60)
Sickle cell nephropathy: new insights into its pathophysiology. (1985) (60)
Evaluation of measures of urinary albumin excretion. (2006) (60)
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy. (2000) (60)
Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition. (1991) (60)
The influence of indomethacin on renal haemodynamics in sickle cell anaemia. (1980) (59)
Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss. (2000) (59)
Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study (2009) (58)
Fasting insulin modifies the relation between age and renal function. (2007) (58)
Association of cognitive function with albuminuria and eGFR in the general population. (2011) (57)
Diuretic Effects of Angiotensin‐Converting Enzyme Inhibition: Comparison of Low and Liberal Sodium Diet in Hypertensive Patients (1987) (57)
Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism? (1998) (56)
Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo. (1997) (56)
Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. (1990) (55)
Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline? (1997) (53)
Effects of Fosinopril and Pravastatin on Carotid Intima-Media Thickness in Subjects With Increased Albuminuria (2005) (53)
Trends in the incidence of treated end-stage renal failure in The Netherlands: hope for the future? (2004) (53)
Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs. (1986) (53)
Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients. (2006) (52)
Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy. (2005) (50)
Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(1-7) in healthy man (2005) (50)
Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome? (1993) (50)
Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria. (2001) (49)
C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort. (2008) (49)
Determinants of Insulin Resistance in Renal Transplant Recipients (2007) (48)
One-Year Change in Kidney Function Is Associated with an Increased Mortality Risk (2012) (48)
Insulin resistance as putative cause of chronic renal transplant dysfunction. (2003) (47)
Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM. (2001) (47)
Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands. (2010) (47)
Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus (2002) (46)
Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects. (2002) (46)
Social participation after successful kidney transplantation (2007) (45)
An ion chromatographic method for the simultaneous determination of inorganic phosphate, bromide, nitrate and sulphate in human serum. (1983) (44)
Relative blood volume measurements during hemodialysis: Comparisons between three noninvasive devices (2007) (44)
Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria? (2004) (44)
Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry. (2007) (44)
Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats. (1999) (43)
Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of Incident Cardiovascular Disease and All-Cause Mortality (2012) (43)
Past Decline Versus Current eGFR and Subsequent Mortality Risk. (2016) (43)
Validation of insulin resistance indexes in a stable renal transplant population. (2005) (43)
The contradiction of stable body mass despite low reported dietary energy intake in chronic haemodialysis patients. (2002) (42)
Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable? (2000) (42)
Influence of age and measure of eGFR on the association between renal function and cardiovascular events. (2010) (41)
Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function. (2000) (41)
What predicts progression and regression of urinary albumin excretion in the nondiabetic population? (2007) (41)
Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease. (1996) (41)
Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength? (2007) (40)
Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. (2014) (39)
Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population (2012) (39)
ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients. (1997) (39)
Anthropometry-based equations overestimate the urea distribution volume in hemodialysis patients. (2001) (39)
Effect of human atrial natriuretic peptide on blood pressure after sodium depletion in essential hypertension. (1986) (39)
Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial. (2004) (39)
Influence of urine creatinine on the relationship between the albumin-to-creatinine ratio and cardiovascular events. (2012) (38)
Clinical Factors Influencing Participation in Society after Successful Kidney Transplantation (2006) (38)
The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate. (2007) (37)
Renal hemodynamics after lung transplantation. A prospective study. (1996) (37)
Renal disease in POEMS syndrome: report on a case and review of the literature. (1994) (36)
Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction. (2004) (36)
Proteinuria and progression of renal disease: therapeutic implications (1997) (35)
Prolonged frozen storage of urine reduces the value of albuminuria for mortality prediction. (2007) (35)
Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study. (1985) (35)
Early detection of progressive chronic kidney disease: is it feasible? (2006) (35)
Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis. (1999) (35)
The role of the cytochrome P450 3A5 enzyme for blood pressure regulation in the general Caucasian population (2005) (34)
Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy. (1992) (34)
Restenosis prevalence and long-term effects on renal function after percutaneous transluminal renal angioplasty. (1986) (34)
ACE Inhibition Preserves Heparan Sulfate Proteoglycans in the Glomerular Basement Membrane of Rats with Established Adriamycin Nephropathy (2000) (33)
Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. (2004) (32)
Screening techniques for detecting chronic kidney disease (2005) (32)
Diagnostic use of angiotensin converting enzyme inhibitors in radioisotope evaluation of unilateral renal artery stenosis. (1989) (31)
Biochemical risk markers: a novel area for better prediction of renal risk? (2005) (31)
Angiotensin-converting enzyme gene I/D polymorphism and renal disease (1999) (30)
Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats (2003) (30)
Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis. (2002) (30)
Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population. (2003) (30)
Low Levels of sRAGE Are Associated With Increased Risk for Mortality in Renal Transplant Recipients (2007) (30)
Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: a cross-sectional study. (2014) (30)
Variability of predialytic, intradialytic, and postdialytic blood pressures in the course of a week: a study of Dutch and US maintenance hemodialysis patients. (2013) (28)
Determination of protein catabolic rate in patients on chronic intermittent hemodialysis: urea output measurements compared with dietary protein intake and with calculation of urea generation rate. (1995) (28)
The effect of phlebotomy on renal function and proteinuria in a patient with congenital cyanotic heart disease. (1983) (28)
Challenges for the present CKD classification system (2010) (28)
Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes. (2003) (28)
Changes in left ventricular diastolic function during hemodialysis sessions. (2013) (27)
Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events. (2012) (27)
Fasting insulin is a stronger cardiovascular risk factor in women than in men. (2009) (27)
Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease. (1999) (27)
Effect of frozen storage on urinary concentration of kidney damage markers. (2012) (27)
Blood pressure in sickle cell disease. (1982) (27)
Glomerular and tubular damage markers in individuals with progressive albuminuria. (2013) (26)
The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population. (2002) (26)
Effect of first myocardial ischemic event on renal function. (2007) (25)
Hypertension and renal disease: role of microalbuminuria. (1996) (25)
Determination of urea kinetics by isotope dilution with [13C]urea and gas chromatography-isotope ratio mass spectrometry (GC-IRMS) analysis. (1997) (24)
Factors Determining Social Participation in the First Year After Kidney Transplantation: A Prospective Study (2007) (24)
Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome (1995) (24)
The angiotensin converting enzyme inhibitor enalapril and its effects on renal function. (1983) (24)
Albuminuria in non-primary renal disease: risk marker rather than risk factor. (2010) (24)
How to measure the prevalence of microalbuminuria in relation to age and gender? (2002) (24)
The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs. (2003) (24)
Relating protein intake to nutritional status in haemodialysis patients: how to normalize the protein equivalent of total nitrogen appearance (PNA)? (1999) (23)
Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? (2012) (23)
Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action. (1991) (23)
Volume homeostasis, angiotensin converting enzyme inhibition, and lithium therapy. (1989) (22)
Isolated microalbuminuria indicates a poor medical prognosis. (2013) (22)
Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease. (2001) (22)
Tubular dysfunction in proliferative lupus nephritis. (1991) (22)
The influence of indomethacin on renal concentrating and diluting capacity in sickle cell nephropathy. (1982) (22)
Dialysis Hypotension: A Role for Inadequate Increase in Arginine Vasopressin Levels? A Systematic Literature Review and Meta-Analysis (2014) (22)
Effects of Relative Blood Volume–Controlled Hemodialysis on Blood Pressure and Volume Status in Hypertensive Patients (2007) (22)
Screening for early chronic kidney disease--what method fits best? (2006) (21)
Urine Albumin-Creatinine Ratio Versus Albumin Excretion for Albuminuria Staging: A Prospective Longitudinal Cohort Study. (2016) (21)
Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function (1999) (21)
Successful management of chronic myeloid leukaemia with leucapheresis during a twin pregnancy. (2007) (21)
Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors. (2010) (21)
Comparison of the yield of different screening approaches to detect chronic kidney disease. (2010) (21)
Atrial natriuretic peptide-induced decreases in renal blood flow in man: implications for the natriuretic mechanism. (1989) (20)
Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy. (2007) (20)
Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats. (1999) (20)
Hemolytic uremic syndrome due to Capnocytophaga canimorsus bacteremia after a dog bite. (1999) (20)
The antiproteinuric effect of antihypertensive agents in diabetic nephropathy. (1992) (20)
Influence of Ultrafiltration Volume on Blood Volume Changes During Hemodialysis as Observed in Day-of-the-Week Analysis of Hemodialysis Sessions (2007) (20)
The Predictive Value of Renal Vascular Resistance for Late Renal Allograft Loss (2006) (20)
Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function. (1984) (20)
Predictors of Progression in Albuminuria in the General Population: Results from the PREVEND Cohort (2013) (20)
Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis. (2000) (20)
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events. (2008) (19)
Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertension. (1985) (19)
Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects. (2002) (19)
Noninvasive measurement of intrarenal blood flow distribution: kinetic model of renal 123I-hippuran handling. (1995) (19)
The Association of Albuminuria With Tubular Reabsorption of Uric Acid: Results From a General Population Cohort (2014) (19)
Renal effects of indomethacin in patients with systemic lupus erythematosus. (1989) (18)
A comparison of analytic procedures for measurement of fractional dextran clearances. (1998) (18)
Prevention of chronic kidney disease: The next step forward! (Review Article) (2006) (18)
Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition. (1996) (18)
Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity? (1984) (18)
High-dose ACE inhibition: can it improve renoprotection? (2002) (17)
Focus on Microalbuminuria to Improve Cardiac and Renal Protection (2009) (17)
Excretion of iodide in 24-h urine as determined by ion-pair reversed-phase liquid chromatography with electrochemical detection. (1988) (17)
Screening for albuminuria with subsequent screening for hypertension and hypercholesterolaemia identifies subjects in whom treatment is warranted to prevent cardiovascular events. (2013) (17)
Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis. (2012) (17)
Aldosterone Assessment in Patients with Menière’s Disease (2001) (17)
Enalapril and the Kidney: Renal Vasodilation and Natriuresis Due to the Inhibition of Angiotensin II Formation (1986) (17)
Urine collection in the freely moving rat: reliability for measurement of short-term renal effects. (1997) (17)
Differences between physicians in the likelihood of referral and acceptance of elderly patients for dialysis-influence of age and comorbidity. (2007) (17)
Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis. (1992) (16)
Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations. (2013) (16)
Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention. (2008) (16)
A method for accurate measurement of GFR in conscious, spontaneously voiding rats. (1997) (16)
Treatment of anemia of nephrotic syndrome with recombinant erythropoietin. (1996) (15)
After all those fat years: renal consequences of obesity. (2004) (15)
Discordant effects of enalapril and lisinopril on systemic and renal hemodynamics (1994) (15)
Cost-effectiveness of screening for proteinuria. (2004) (15)
Predictors of Angiotensin-Converting Enzyme Inhibitor–Induced Reduction of Urinary Albumin Excretion in Nondiabetic Patients (2006) (15)
Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable. (1999) (14)
Renin inhibition improves pressure natriuresis in essential hypertension. (2000) (14)
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial. (2005) (14)
Proteinuria: a risk factor for pregnancy-related renal function decline in primary glomerular disease? (1995) (14)
Acute renal failure after overdose of labetalol. (1986) (14)
Screening for chronic kidney disease can be of help to prevent atherosclerotic end-organ damage. (2012) (14)
Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects. (1983) (14)
Renal hemodynamic effects of candesartan in normal and impaired renal function in humans. (1997) (13)
Measurement of glomerular charge selectivity in non-diabetic renal disease. (1997) (13)
Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects. (2006) (13)
Sample dilution: a methodological pitfall in the measurement of tissue but not serum ace-activity. (1998) (13)
Lisinopril in hypertensive patients with renal function impairment. (1990) (13)
Exercise induced macroscopic haematuria: run for a diagnosis? (1999) (13)
Effect of indomethacin in two siblings with a renin-dependent hypertension, hyperaldosteronism and hypokalemia. (1980) (13)
Angiotensin-converting enzyme inhibition-induced changes in hippurate renography and renal function in renovascular hypertension. (1996) (13)
Angiotensin II receptor antagonist treatment lowers plasma total and very low + low density lipoprotein cholesterol in Type 1 diabetic patients with albuminuria without affecting plasma cholesterol esterification and cholesteryl ester transfer. (2000) (13)
Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat. (1998) (13)
Corticosteroid use and its association with microalbuminuria in the adult population. (2003) (13)
Stability of creatinine and cystatin C in whole blood. (2013) (12)
Prevention of renal function loss after non-renal solid organ transplantation--how can nephrologists help to keep the kidneys out of the line of fire? (1999) (12)
Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension. (1983) (12)
Screening and monitoring for albuminuria: the performance of the HemoCue point-of-care system. (2008) (12)
The influence of indomethacin on renal acidification in normal subjects and in patients with sickle cell anemia. (1983) (11)
Restenosis of the renal artery after percutaneous transluminal renal angioplasty: an inevitable outcome? (1983) (11)
Is the antiproteinuric response to inhibition of the renin-angiotensin system less effective during the night? (1997) (11)
The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment. (1996) (11)
Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study. (2010) (11)
Renal toxicity of the anticancer drug fostriecin (1998) (11)
Mechanism of the antiproteinuric effect of angiotensin-converting enzyme inhibition. (1990) (10)
Nephrotic syndrome preceding Hodgkin's disease by 42 months. (1986) (10)
Effect of High and Low Ultrafiltration Volume during Hemodialysis on Relative Blood Volume (2006) (10)
Angiotensin-I converting enzyme inhibition: clinical effects in chronic renal disease. (1991) (10)
Beta-2-microglobulin in sickle cell anaemia. Evidence of increased tubular reabsorption. (1981) (10)
I/D polymorphism of the angiotensin converting enzyme gene: a clue to the heterogeneity in the progression of renal disease and in the renal response to therapy? (1997) (10)
The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics. (1992) (10)
Better understanding of ADPKD results in potential new treatment options: ready for the cure? (2008) (10)
Screening for elevated albuminuria and subsequently hypertension identifies subjects in which treatment may be warranted to prevent renal function decline: Clinical Epidemiology in Nephrology (2016) (10)
The metabolic response to ingested protein is normal in long-term hemodialysis patients. (2004) (10)
What to measure-albuminuria or total proteinuria? (2011) (9)
Is the antiproteinuric effect of dipyridamole hemodynamically mediated? (1988) (9)
Complications of liver cysts in patients with adult polycystic kidney disease. (1990) (9)
The tubular reabsorption of phosphate in sickle-cell nephropathy. (1978) (9)
Drug‐induced renal function impairment: a population‐based survey (2003) (9)
Effect of antiproteinuric treatment on the lipid profile in nondiabetic renal disease. (1997) (9)
Comparison of cardiac positron emission tomography perfusion defects during stress induced by hemodialysis versus adenosine. (2012) (9)
Drug-induced changes in renal hippurate clearance as a measure of renal blood flow. (1995) (9)
Relation of electrocardiographic abnormalities to levels of serum C-reactive protein. (2003) (8)
Comparison of amino acid oxidation and urea metabolism in haemodialysis patients during fasting and meal intake. (2004) (8)
Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands--investigation of explanatory variables. (2012) (8)
Treatment of idiopathic membranous nephropathy: the dilemma of who, when, and how. (1995) (8)
Measurement of coronary calcium scores or exercise testing as initial screening tool in asymptomatic subjects with ST-T changes on the resting ECG: an evaluation study (2007) (8)
Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension. (1992) (8)
Renal and Systemic Effects of the Renin Inhibitor Remikiren in Patients with Essential Hypertension (1995) (7)
Exploration of the difference in incidence of renal replacement therapy in elderly patients in Flanders and the Netherlands--a comparison of referral policy. (2012) (7)
Renal effects of ketanserin in essential hypertension. (1986) (7)
Re: Adey et al. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab 278: E219-E225, 2000. (2001) (7)
Low calorie intake in dialysis patients: an alternative explanation. (1999) (7)
The Abnormal Renal Vasodilator Response to D1-Like Receptor Stimulation in Conscious SHR Can Be Normalized by AT1 Blockade (2004) (6)
Effect of Nocturnal Haemodialysis on Body Composition (2014) (6)
Renoprotective therapy: is it blood pressure or albuminuria that matters? (2005) (6)
Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition? (2002) (6)
Oxidative metabolism appears to be reduced in long-term hemodialysis patients. (2005) (5)
The effect of screening for cardio-renal risk factors on drug use in the general population. (2007) (5)
The effect of continuous subcutaneous insulin infusion on renal function in type I diabetic patients with and without proteinuria. (1985) (5)
The mechanism and diagnostic value of angiotensin I converting enzyme inhibition renography. (1991) (5)
Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients. (1992) (5)
Vasopressin and microalbuminuria: is it vasopressin per se or is it salt intake? (2010) (4)
Effect of mild charge modification of albumin on renal excretion in the rat. (1988) (4)
Concurrent presentation of hemolytic uremic syndrome in two adult siblings: effects of plasma therapy on hemolysis and renal function. (1994) (4)
Relief of renal artery stenosis: a tool to improve or preserve renal function in renovascular disease? (1990) (4)
The role of prostaglandins and renin in sickle-cell nephropathy. A hypothesis. (1978) (4)
Twenty-four hour urinary urea excretion and 9-year risk of hypertension: the PREVEND study (2013) (4)
[Methods of collecting urine for the determination of microalbuminuria: time for consensus]. (2004) (4)
Losartan in patients with renal insufficiency. (1995) (4)
Feasibility of measuring renal blood flow by phase-contrast magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease (2015) (4)
Unilateral renal parenchymal disease with contralateral renal artery stenosis of the fibrodysplasia type. (1989) (3)
Renal tubular sensitivity to atrial natriuretic factor in essential hypertension (1994) (3)
[Psychosocial consequences of screening for microalbuminuria and for some other risk factors]. (2000) (3)
Optimizing the renal response to ace inhibition: a strategy toward more effective long-term renoprotection. (1997) (3)
Membrane Biocompatibility Does Not Affect Whole Body Protein Metabolism during Dialysis (2005) (3)
Indomethacin and ibuprofen-induced reversible acute renal failure in a patient with systemic lupus erythematosus. (1987) (2)
Salt-The Forgotten Renal Risk Factor: Sodium Intake Affects Urinary Albumin Excretion Especially in Overweight Subjects. J Intern Med 256: 324-330, 2004. (2005) (2)
Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat. (2003) (2)
Why does elevated plasma homocysteine result in severe microvascular injury, but not glomerular damage? (2003) (2)
The effect of transluminal dilation of stenosed renal arteries on kidney function. (1983) (2)
Differences between physicians in the likelihood of referral and acceptance of elderly patients for dialysis influence of age and comorbidity (2008) (2)
Is cystatin C the answer to detecting progression in CKD? (2011) (2)
Renal 131I-hippurate clearance overestimates true renal blood flow in the instrumented conscious dog. (1996) (2)
[Autosomal dominant polycystic kidney disease: new insights and possible drugs]. (2009) (1)
Can continuous intraperitoneal infusion of 125I-iothalamate and 131I-hippuran be used for measurement of GFR in conscious rats? (1998) (1)
Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism? (1977) (1)
[Population screening for urinary protein loss: a sensible action]. (2007) (1)
Psychosocial consequences of screening for albuminuria and certain other risk factors. (2001) (1)
Incidence of hyperkalaemia induced by indomethacin. (1985) (1)
Diabetic nephropathy--what does it cause to develop? (1988) (1)
Atrial natriuretic peptides: a new dimension in the understanding of volume homoeostasis? (1986) (1)
Involvement of atrial natriuretic peptide in long-term regulation of sodium-homeostasis in man. (1988) (1)
Short-term effects of percutaneous transluminal renal angioplasty on renal function in unilateral renal artery stenosis. (1986) (1)
Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment. (1994) (1)
[Clinical reasoning and decision-making in practice. A woman with hypokalaemia]. (2003) (1)
[Pasteurella multocida sepsis in a patient with sickle cell anemia]. (1975) (0)
Renal function during antihypertensive treatment. (1995) (0)
[A patient with recurrent polychondritis, vasculitis and local focal glomerulonephritis]. (1988) (0)
Antibiotic dose adjustment in renal insufficiency. (1992) (0)
[Effect of protein restriction on deterioration of kidney function]. (1997) (0)
Treating Microalbuminuria-Cosmetic Exercises with Urine Chemistry or Effective Reduction of Clinical Events?: Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects with Microalbuminuria. Circulation 110: 2809-2816, 2004. (2005) (0)
Equations used to predict glomerular filtration rate perform poorly in kidney transplant recipients (2006) (0)
D2-Like Receptor Stimulation Decreases Effective Renal Plasma Flow and Glomerular Filtration Rate in Spontaneously Hypertensive Rats (2002) (0)
THE PREDICTIVE VALUE OF RENAL VASCULAR RESISTANCE FOR RENAL GRAFT LOSS (2004) (0)
THE METABOLIC SYNDROME IS ASSOCIATED WITH IMPAIRMENT OF LONG-TERM RENAL GRAFT FUNCTION: NOT ALL COMPONENT CRITERIA CONTRIBUTE EQUALLY. (2004) (0)
[Treatment of renovascular hypertension: surgery or dilatation?]. (1986) (0)
[Results of percutaneous transluminal angioplasty in renal artery stenosis in 1978-1986]. (1989) (0)
[The prevention of renal failure has to improve]. (2015) (0)
Have rational therapeutic principles emerged in treating hypertension in chronic renal failure? (1993) (0)
Management of chronic renal failure. (1992) (0)
Hypercalcaemia associated with plasma infusion therapy for thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Report of two cases. (1985) (0)
[Renal effects of angiotensin-converting enzyme inhibitors: from the feared side effect to the desired treatment goal]. (1991) (0)
[A diabetic patient with kidney insufficiency]. (1983) (0)
[Angiotensin-converting enzyme inhibitors]. (1988) (0)
Thromboxane antagonism in lupus nephritis. (1989) (0)
[Angiotensin-converting enzyme inhibitors in the treatment of proteinuria]. (1991) (0)
The association of albuminuria and high-sensitivity C-reactive protein with the efficacy of HMG-coenzyme A reductase inhibitors for cardiovascular event prevention (2016) (0)

This paper list is powered by the following services:

Paul E. De Jong's Academic­Influence.com Rankings

Paul E. De Jong's Degrees

Why Is Paul E. De Jong Influential?

Paul E. De Jong's Published Works

Published Works

Paul E. De Jong's AcademicInfluence.com Rankings